Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2 Step ATG Combined With Tacrolimus and Mini Methotrexate for Prevention of Acute GVHD
NCT06315309Phase 2Recruiting
- Sponsor
- University of Alabama at Birmingham
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of antithymocyte globulin rabbit in graft-versus-host disease (GVHD), sponsored by University of Alabama at Birmingham. Started Apr 2025; status: recruiting.
02
Drugs
antithymocyte globulin rabbit
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT06315309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06315309.